Article Text

Download PDFPDF
Double-blinded, placebo-controlled study to evaluate an antipruritic shampoo for dogs with allergic pruritus
  1. J. Schilling, and
  2. R. S. Mueller, Prof., MACVSc (Canine Medicine), DipACVD, FANZCVSc (Dermatology), DipECVD, FAAAAI
  1. Small Animal Medicine Clinic, Centre for Clinical Veterinary Medicine, Ludwig Maximilian University, Veterinaerstrasse 13, 80539 Munich, Germany
  1. Correspondence to R. S. Mueller, e-mail: Ralf.Mueller{at}

Shampoo therapy is frequently used on pruritic dogs. However, there are few double-blinded, placebo-controlled studies of this form of therapy. This randomised, double-blinded, placebo-controlled study evaluated the efficacy of a commercial medicated shampoo (DermaTopic; Almapharm) containing chlorhexidine, lactoferrin, piroctone olamine, chitosan and essential fatty acids in 27 dogs with mild to moderate allergic pruritus without secondary skin infections. All dogs received shampoo therapy with either DermaTopic or a shampoo vehicle as placebo twice weekly for four weeks. The extent of pruritus was evaluated before the study and then on a daily basis by the owners using a visual analogue scale. Before beginning the treatment and after four weeks, the skin lesions were evaluated by an experienced clinician with a validated lesion score (Canine Atopic Dermatitis Extent and Severity Index – CADESI). The pruritus was reduced significantly by both DermaTopic and placebo. However, there was no significant difference between both groups. There was no statistically significant difference in the CADESI scores pre- and post-treatment in either group or between the two types of treatment. This study provides further evidence of the benefit of shampoo therapy for pruritic dogs.

View Full Text

Statistics from


  • Correction notice This article has been corrected since it was published (Veterinary Record 2012;171:97). The images and captions for Fig 1 and Fig 2 were mismatched.

  • Provenance not commissioned; externally peer reviewed

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.